In Depth 5 Jan 2023
Navignostics maps tumor proteomes to improve precision oncology
…a startup pitch last year presented by Jana Fischer, CEO of the Swiss startup Navignostics, this lack of guidance can result in failed clinical trials and patients getting suboptimal treatments…